1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigarette Smoke Extract Compared to Healthy
(
- Contribution to journal › Article
- 2022
-
Mark
Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women
(
- Contribution to journal › Article
-
Mark
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
(
- Contribution to journal › Article
- 2020
-
Mark
Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death - A National Register Study
(
- Contribution to journal › Article
- 2019
-
Mark
Effects of baseline symptom burden on treatment response in COPD
(
- Contribution to journal › Article
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
ST2 predicts mortality in patients with acute hypercapnic respiratory failure treated with noninvasive positive pressure ventilation.
(
- Contribution to journal › Article
- 2018
-
Mark
Toward effective prescription of inhaled corticosteroids in chronic airway disease
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
(
- Contribution to journal › Article
-
Mark
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
(
- Contribution to journal › Article